Berberine
C20H18NO4
336.00
mp......203-204
Berberine is a quaternary ammonium salt from the protoberberine group of isoquinoline alkaloids. It is found in such plants asBerberis [e.g. Berberis aquifolium (Oregon grape), Berberis vulgaris (barberry), Berberis aristata (tree turmeric)], Hydrastis canadensis (goldenseal), Xanthorhiza simplicissima (yellowroot), Phellodendron amurense[2] (Amur cork tree), Coptis chinensis(Chinese goldthread 黄连素 or Huang Lian Su), Tinospora cordifolia, Argemone mexicana (prickly poppy), and Eschscholzia californica (Californian poppy). Berberine is usually found in the roots, rhizomes, stems, and bark.[citation needed]
Due to Berberine's strong yellow color, Berberis species were used to dye wool, leather and wood. Wool is still today dyed with berberine in northern India. Under ultraviolet light, berberine shows a strong yellow fluorescence,[3] so it is used in histology forstaining heparin in mast cells.[4] As a natural dye, berberine has a colour index of 75160.
1H NMR
(400 MHz, CD3OD) δ: 9.75 (1H, s, H-8), 8.69 (1H, s, H-13), 8.10 (1H, d, J = 8.3 Hz, H-11), 7.98 (1H, d, J = 8.4 Hz, H-12), 7.64 (1H, s, H-1), 6.94 (1H, s, H-4), 6.09 (2H, s, OCH2O), 4.91 (2H, t, J = 6.4, H-6), 4.18 (3H, s, 9-OCH3), 4.09 (3H, s, 10-OCH3), 3.24 (2H, t, J = 6.4 Hz, H-5) 13 C NMR (100 MHz, CD3OD) δ: 151.0 (C-10), 150.8 (C-3), 148.7 (C-2), 144.6 (C-9), 145.2 (C-8), 138.5 (C-13a), 134.0 (C-12a), 130.7 (C-4a), 126.8 (C-11), 123.3 (C-12), 122.1 (C-8a), 120.7 (C-13b), 120.3 (C-13), 108.2 (C-4), 105.3 (C-1), 102.5 (OCH2O), 61.3 (C-9, OCH3), 56.4 (C-10, OCH3), 56.0 (C-6), 27.0 (C-5) [1H,13C] 2D NMR Spectrum MASShttp://scialert.net/fulltext/?doi=rjmp.2008.1.9 |
H. Raja Naika and V. Krishna, 2008. Micropropagation, Isolation and Characterization of Berberine from Leaves of Naravelia zeylanica(L.) DC.. Research Journal of Medicinal Plant, 2: 1-9.
DOI: 10.3923/rjmp.2008.1.9
URL: http://scialert.net/abstract/?doi=rjmp.2008.1.9
DOI: 10.3923/rjmp.2008.1.9
URL: http://scialert.net/abstract/?doi=rjmp.2008.1.9
The Soxhlet extraction of 100 g of dried leaves yielded 12 g of crude methanolic extract. Ten gram of the crude extract yielded 270.0 mg of total alkaloids from the leaves extract. The presence of the alkaloid confirmed qualitatively by Dragendorff’s, Mayer’s and Wagner’s tests. (Kokate et al., 1990) The separation of berberine was done by preparative TLC method and the yield was 70 mg from in vivo leaf extract. The constituent was characterized by subjecting it to IR, 1H NMR and MASS spectral studies.
Spectral Characterization of Code RA
IR (Kbr): | 2820 cm-2 (C-H str) 1597 cm-2 (C = C, C = N str) 1354-1383 cm-2 (C-H deformation) 1060 cm-2 (C-O str) (Fig. 2) |
1H NMR (CDCL3): | δ 1.75 (m, 2H,-CH2-) δ 2.4 (m, 2H, N+-CH3) δ 3.9 (s, 6H, 2 X OCH3) δ 6.0 (s, 2H, O-CH2-O) δ 6.6-9.4 (m, 6H, Ar-H) (Fig. 3) |
Fig. 2: | IR spectrum of berberine |
Fig. 3: | 1H NMR spectrum of berberine |
Mass spectra (EI-MS): | Molecular formula:C20H19NO4 Molecular weight:336.37 EIMS: (m/z):336 (m+, 20%), 322 (35%), 281 (50%), 267 (38%), 207 (76%), 147 (100%) (Fig. 4) |
Berberine | |
---|---|
Identifiers | |
CAS number | 2086-83-1 |
PubChem | 2353 |
ChemSpider | 2263 |
UNII | 0I8Y3P32UF |
DrugBank | DB04115 |
ChEBI | CHEBI:16118 |
ChEMBL | CHEMBL12089 |
Jmol-3D images | Image 1 |
Properties | |
Molecular formula | C20H18NO4+ |
Molar mass | 336.36122 g/mol |
Appearance | yellow solid |
Melting point | 145°C[1] |
Solubility in water | slowly soluble[1] |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) |
Title: Berberine
CAS Registry Number: 2086-83-1
CAS Name: 5,6-Dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium
Additional Names: 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)berbinium; umbellatine
Molecular Formula: [C20H18NO4]+
Literature References: Tautomeric alkaloid widely distributed in nine or more botanical familes but occurs most frequently inBerberidaceae. A component of many traditional medicines, first isolated in 1826. Structure: Perkin, Robinson, J. Chem. Soc. 97,305 (1910). Biosynthesis: J. R. Gear, I. D. Spenser, Can. J. Chem. 41, 783 (1963). Pharmacology: Fukuda et al., Chem. Pharm. Bull. 18, 1299 (1970). Total synthesis: Kametani et al., J. Chem. Soc. C 1969, 2036. NMR: G. Blasko et al., Heterocycles 27, 911 (1988). HPLC determn in biological fluids: C.-M. Chen, H.-C. Chang, J. Chromatogr. B 665, 117 (1995). Clinical evaluation in malaria: W. D. Sheng et al., East Afr. Med. J. 74, 283 (1997). Review of biological activities: F. E. Hahn, J. Ciak, in Antibioticsvol. 3, D. Gottlieb et al., Eds. (Springer-Verlag, New York, 1975) pp 577-584; of chemistry, distribution and use: R. S. Thakur, S. K. Srivastava, Curr. Res. Med. Aromat. Plants 4, 249-272 (1982). Review of antidiarrheal action: A. W. Baird et al., Adv. Drug Delivery Rev. 23, 111-120 (1997).
Properties: Yellow needles from ether, mp 145°: Gadamer, Arch. Pharm. 243, 33 (1905). uv max: 265, 343 nm. pK 2.47.
Melting point: mp 145°: Gadamer, Arch. Pharm. 243, 33 (1905)
pKa: pK 2.47
Absorption maximum: uv max: 265, 343 nm
Derivative Type: Acid sulfate
Additional Names: Berberine bisulfate
Molecular Formula: C20H19NO
.....................
Berberine is isoquinoline alkaloid. Molecular formula: [C20H18NO4]+, molecular weight: 336.37 and its chemical structure is as follows:
- The Merck Index, 10th Ed. (1983), p.165, Rahway: Merck & Co.
- ^ Zhang, Q; Cai, L; Zhong, G; Luo, W (2010). "Simultaneous determination of jatrorrhizine, palmatine, berberine, and obacunone in Phellodendri Amurensis Cortex by RP-HPLC". Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 35 (16): 2061–4. doi:10.4268/cjcmm20101603.PMID 21046728.
- ^ Weiß, Dieter (2008). "Fluoreszenzfarbstoffe in der Natur" (in German). Retrieved 17 July 2009.
EXTRA'S YOU WOULD LIKE
Berberine, also called umbellatine, is an isoquinoline alkaloid represented by the following formula, which is a major active component in such plants as Coptidis chinensis Franch., Berberis amurensis Rupr., Berberis sargentiana Schneid andNandina domestica etc. Clinically, berberine is mainly used to treat diarrhea caused by bacteria with the most important advantage of having little side effects. Berberine has been used as a broad spectrum antibiotic for many years, and is effective on inhibition and elimination of various Gram-positive and Gram-negative bacteria, fungi, moulds, viruses, protozoa and nematode.
Structure of Berberine
Since 1950s, a large number of animal experiments and clinical trials have been carried out by some specialists, researchers and clinicians with berberine hydrochloride which is widely used in clinic, and the results showed that berberine are effective on the therapy of diabetes mellitus and their complications besides being antibiotic. Some research literatures are summarized in the following Table I:
TABLE I | ||
Summary of animal experiments and clinical trials on treating diabetes mellitus with berberine | ||
Authors | Results of animal studies and clinical trials | Literature |
Qiming CHEN, | Berberine possesses advantages of both sulfonylureas and | Acta |
Mingzhi XIE | biguanides. It can lower blood glucose levels of both normal mice | Pharmaceutica |
(Institute of | and alloxan-induced diabetic mice, and antagonize the increase of | Sinica, 1986, |
Materia Medica, | blood glucose levels induced by exogenous glucose or | 21(6): 401-406. |
Chinese Academy | epinephrine. It has powerful effect on lowering blood glucose | |
of Medical | levels and long action time lasting up to 5-6 hours. Berberine can | |
Sciences) | also improve abnormal blood coagulation and prevent | |
atherosclerosis. It had a significant effect on lowering blood | ||
glucose at a dose of 40 mg/kg. | ||
Yanxie NI, et. al. | 60 cases of type 2 diabetic patients were treated with berberine | Journal of |
(The 208th hospital | and the treatment was lasted for 1-3 months. The results showed | Integrated |
of PLA) | that the fasting blood glucose decreased averagely by 5.1 mmol/L | Traditional and |
and the efficiency was 90%. It was found by pathologic | Western | |
examinations that berberine could promote the regeneration and | Medicine, 1988, | |
functional recovery of pancreatic beta-cells. No abnormality was | 8(12): 711-713. | |
observed for all patients in the hepatic and renal functions and | ||
hemogram during the treatment and no obvious adverse effect | ||
was found. | ||
Guoying LIU | 30 cases of type 2 diabetic patients were treated with berberine | New use of old |
(Pengze traditional | and the efficiency was 90%. Berberine was significantly effective | drug, 1992, 1: 3-4. |
Chinese medical | for the patients with light or moderate diabetes mellitus. In | |
hospital, Jiujiang, | addition, it also showed effects on lowering blood pressure and | |
Jiangxi) | blood fat, and preventing infection and the occurrence of | |
complication etc. | ||
Mianrong YU, et. | 75 cases of type 2 diabetic patients were treated with berberine | Beijing Medical |
al. (Builder | and the efficiency was 69.33%. Three diabetic symptoms, i.e. | Journal, 1994, |
hospital of Beijing) | polyuria, polydipsia and polyphagia, disappeared for all patients | 16(2): 117. |
within two weeks after administration of berberine accompanying | ||
the decrease of blood glucose. The diabetic patients have been | ||
treated with berberine and observed for 4 years, and none of them | ||
was observed with adverse effects or hypoglycemia regardless of | ||
dose. In addition, 11 patients had normal blood glucose with | ||
reduced dose more than 3 years. | ||
Faguang HU, et. al. | 60 cases of type 2 diabetic patients were treated with berberine | The Practical |
(The Shanxuan | and the efficiency was 90%. Berberine had a mild and lasting | Journal of |
people's hospital, | effect on lowering blood glucose, making the blood glucose start | Integrating of |
Henan) | to lower after about 2 weeks, and achieving its maximum curative | Chinese with |
effect within 8 weeks. For all patients, berberine made the | Modern Medicine, | |
diabetic symptoms disappearing or being relieved and showed | 1995, 8(6): | |
good effects on common diabetic complications. In addition, 4 | 358-359. | |
patients with overweight recovered their normal weights. No | ||
toxic and/or adverse effects were observed. | ||
Jiaqing ZHANG | Berberine has a certain effect on increasing insulin sensitivity and | Liaoning Journal |
(Changhai hospital, | can improve insulin resistance with an insulin action index (IAI) | of Practical |
the 2nd military | similar to metformin. | Diabetology, |
surgeon college) | 1999, 1(4): 56-57. | |
Changshan LIU, et | Renal failure often occurs to most of diabetic patients with the | Chinese Journal of |
al. (Weifang | deterioration of conditions. Berberine, a traditional Chinese drug, | Diabetes, 1996, |
medical college, | has a significant effect on reversing diabetic renal failure and | 4(3): 163-166. |
Shandong) | inhibiting the activities of the polyol and kidney aldose reductases | |
of diabetic mice to lower urine protein. | ||
Jinhua TONG | 49 cases of type 2 diabetic patients were treated with berberine | New Journal of |
(Sanitation School | and the efficiency was 63.3%. Berberine can suppress | Traditional |
of Fengtai, Anhui) | glyconeogenesis and glycogenolysis, slow down insulin | Chinese Medicine, |
metabolism and promote the sensitivity of peripheral tissue cells | 1997, 29(3): | |
to insulin by lowering the activity of the sympathetic nerve and | 33-34. | |
inhibiting the adrenal cortical function. It can also promote the | ||
regeneration and functional recovery of pancreatic cells. | ||
Huading YU, | The effect of berberine on treating non-insulin dependent diabetic | Medical Journal of |
Laiwen YAN | patients was evaluated. The patients were divided randomly into 2 | Communications, |
(Shanghai seaman | groups, and each group had 30 persons. One group took berberine | 1995, 9(4): 45. |
hospital) | and another took Diamicron. After 4 weeks treatment, the | |
variations of the concentrations of blood glucose and blood serum | ||
insulin were compared between the two groups, and the results | ||
showed that the two groups had similar curative effects and no | ||
severe adverse effects were observed. | ||
Yunfei ZHANG | For 20 cases of type 2 diabetic patients, their conditions were not | Chinese Journal of |
(Hangzhou | improved significantly after they took oral anti-diabetic drugs for | Integrated |
sanatorium of Air | lowering blood glucose such as D860 and glibenclamide etc. | Traditional and |
Force) | Then, they were treated with berberine. The fasting blood glucose | Western |
levels of all patients were lowered to normal levels 3 months | Medicine, 1999, | |
later. The effect of berberine on lowering blood glucose was | 19(9): 567. | |
dependent on dose, and no side effects such as hypoglycemia | ||
were observed. | ||
Hong ZHU, Wei | 112 cases of type 2 diabetic patients were treated with berberine | Journal of Jining |
DAI (Affiliated | and the efficiency was 90%, which showed that berberine had a | Medical College, |
hospital of Jining | good effect on lowering blood glucose. Specifically, berberine | 1999, 22(3): 67. |
medical college) | had mild and lasting effect of lowering blood glucose without | |
severe toxicity, side effects and damages to liver and renal | ||
function, and had good curative effect on common complications | ||
of diabetes mellitus. | ||
Litian SHI, et al. | 68 cases of type 2 diabetic patients were treated with berberine. | Shanxi Clinical |
(Taiyuan | The blood glucose levels of the patients were lowered | Medicine, 2000, |
commercial staff | significantly, and the total efficiency was 86.8%. The action | 9(3): 181-182. |
hospital) | mechanism of berberine on lowering blood sugar was multiple. | |
The blood serum insulin levels of the patients increased | ||
significantly after the treatment. | ||
Dongkou WANG | 57 cases of type 2 diabetic patients were treated with a second | Zhejiang Journal |
(Taizhou Health | generation sulfonylureas drug alone or in combination with | of Integrated |
center, Jiangsu) | metformin. However, secondary failure occurred 3 years later. | Traditional |
Thus, berberine was taken additionally. The blood glucose levels | Chinese and | |
of the patients were lowered more or less 1 month later, and total | Western | |
efficiency was 81%. | Medicine, 2002, | |
12(1): 50. | ||
Jiandong JIANG et | Berberine can interact with insulin receptors and increase | CN01121906.8 |
al. | significantly the expressions of insulin receptor genes and | |
peroxisome proliferator activated receptor genes. Therefore, | ||
berberine can be used as an insulin sensitizer to treat type 2 | ||
diabetes mellitus alone or in combination with insulin or other | ||
type 2 diabetic drugs. | ||
Kaimin WU | Highly soluble berberines such as berberine sulfate and berberine | WO03090749A1, |
phosphate etc. are easily dissolved in water, which may improve | CN1771944A | |
the absorption of the drugs in organism and thus enhance | ||
significantly their curative effect. Thus, they can be used to treat | ||
and prevent diabetes mellitus or its complications. | ||
Recently, berberine has been widely used to treat type 2 diabetes mellitus in clinic. It was found in an initial research that the antihyperglycemic activity of berberine was in association with its activities of resisting hyperglycemic hormones and promoting the regeneration and functional recovery of pancreatic beta-cells (Hongyan ZHENG, Weiren XU, Chinese herbal medicine. 2004, 35: 708-711). Such research showed that 5-100 μmol of berberine could increase the glucose consumption in HepG2 cells by 32-60%, but it did not stimulate βTC3 cells to secrete insulin. So it was concluded that the antihyperglycemic activity of berberine acted by increasing the glucose consumption of liver cells instead of stimulating to secrete insulin, i.e., the antihyperglycemic activity of berberine acted through liver cells without depending on insulin.
Juan WANG (Juan WANG, China and foreign medical Journal. 2004, 2(12): 65-66) reported that it was observed clinically that the blood glucose levels decreased and the blood serum insulin levels increased when berberine was used to treat diabetes mellitus, which indicated that berberine could promote the regeneration and functional recovery of pancreatic beta-cells besides its resistance to the hyperglycemic hormones. Berberine can also inhibit gluconeogenesis and improve glycolysis, thereby lowering the blood glucose. Thus, the antihyperglycemic activity of berberine belongs to the field of insulin sensitizer. Berberine also has positive effects on preventing diabetes mellitus complications because of its activities of anti-hypertension, anti-hyperlipidemia and anti-infection.
EXTRA